Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir

J Antimicrob Chemother. 2013 May;68(5):1208-9. doi: 10.1093/jac/dks518. Epub 2013 Jan 20.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antiviral Agents / administration & dosage
  • Antiviral Agents / adverse effects
  • Bosentan
  • Drug Interactions
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • Hepatitis B / complications
  • Hepatitis B / drug therapy*
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Humans
  • Male
  • Mental Disorders / chemically induced*
  • Middle Aged
  • Nervous System Diseases / chemically induced*
  • Oligopeptides / administration & dosage
  • Oligopeptides / adverse effects*
  • Sulfonamides / administration & dosage
  • Sulfonamides / adverse effects*

Substances

  • Antiviral Agents
  • Oligopeptides
  • Sulfonamides
  • telaprevir
  • Bosentan